ArticleInflammation and regeneration2026
Age-related downregulation of dihydrotestosterone-inactivating enzymes in human scalp sebaceous glands.
Article in Inflammation and regeneration, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAging alters the systemic steroid environment, including reductions in circulating androgens. In peripheral tissues, androgen exposure is regulated mainly by local steroid metabolism, which can activate or inactivate androgens independently of systemic concentrations. In the scalp, 5α-reductase-mediated generation of dihydrotestosterone (DHT) has been studied extensively in relation to conditions such as androgenetic alopecia. In contrast, age-related regulation of DHT-inactivating pathways, including the aldo-keto reductase family 1 member C (AKR1C) family, remains insufficiently defined.
methodsWe examined AKR1C1-4 expression in scalp tissues from individuals of different ages, sexes, and hair loss conditions using immunohistochemistry (IHC), quantitative PCR (qPCR), and reanalysis of publicly available RNA-sequencing (RNA-seq) datasets. Androgen receptor (AR) localization was assessed in multiple scalp compartments. AKR1C expression was also analyzed in immortalized human sebaceous gland cells (SEB-1) and dermal papilla cells (DPCs). In addition, the effect of sulforaphane on AKR1C expression was evaluated.
resultsAKR1Cs were strongly expressed in male sebaceous glands (SGs) but declined with age. AKR1C4, previously considered liver specific, was detected in SGs and hair follicles (HFs) by IHC and further confirmed by qPCR in SEB-1 cells and DPCs. AR expression was predominant in SGs, with lower levels in sweat glands, the epidermal granular layer, and the HF infundibulum, but not detected in dermal papillae and bulge regions. AR localization was cytoplasmic in the epidermis but nuclear in SGs and sweat glands, and was unaffected by age, sex, or hair loss condition. Sulforaphane treatment upregulated AKR1C expression in both SEB-1 cells and DPCs.
conclusionsWe identify scalp SGs as a principal site of AR expression and AKR1C-mediated androgen inactivation, including AKR1C4, and demonstrate that AKR1C expression in SGs is sex dependent and declines with age. These findings suggest that age-associated changes in SG steroid metabolism may influence local androgen metabolism within the scalp microenvironment, with implications for HF homeostasis during aging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.